Geneva
Geneva non-profit drugmakers unite as global health funding shrinks
Three Geneva-based non-profit drug developers are joining forces as funding for global health innovation comes under pressure. Their work includes treatments for malaria in newborns, hepatitis C and drug-resistant infections that commercial pharmaceutical companies have often neglected.
AI
25 agosto 2026About our editorial process
AI
SWI swissinfo.chArticle content structure is incomplete. Please refresh or contact support.